Direct immunofluorescence (DIF), indirect immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA) are used for the laboratory diagnosis of bullous pemphigoid (BP)
Background: Direct immunofluorescence (DIF) testing is an important procedure in the diagnosis of au...
The purpose of indirect immunofluorescence microscopy is to detect circulating antibodies in patient...
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigo...
Bullous pemphigoid (BP) is an autoimmune blistering skin disease. Autoantibodies to BP180 and BP230 ...
Autoimmmune bullous diseases of skin and mucosa are uncommon, disabling, and potentially lethal dise...
BACKGROUND: Pemphigus is one of the potentially fatal autoimmune blistering diseases. An early and a...
We studied sera from 59 patients with bullous pemphigoid (BP) and 25 control subjects (normal volunt...
Bullous pemphigoid is associated with antibodies to a 230 kDa and a 180 kDa protein. In a literature...
The distributions in deposition of immunoreactants in bullous pemphigoid before and after initiating...
Background: There are several methods for the diagnosis of autoimmune bullous disease. Direct immuno...
BACKGROUND Direct immunofluorescence microscopy (DIF) studies constitute the gold standard for di...
The subepidermal immunobullous diseases bullous pemphigoid (BP), cicatricial pemphigoid (CP), pemphi...
There are a number of controversies relating to studies of bullous pemphigold (BP) antigens from dif...
Direct immunofluorescence plays an important role in the diagnosis of autoimmune bullous diseases. T...
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigo...
Background: Direct immunofluorescence (DIF) testing is an important procedure in the diagnosis of au...
The purpose of indirect immunofluorescence microscopy is to detect circulating antibodies in patient...
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigo...
Bullous pemphigoid (BP) is an autoimmune blistering skin disease. Autoantibodies to BP180 and BP230 ...
Autoimmmune bullous diseases of skin and mucosa are uncommon, disabling, and potentially lethal dise...
BACKGROUND: Pemphigus is one of the potentially fatal autoimmune blistering diseases. An early and a...
We studied sera from 59 patients with bullous pemphigoid (BP) and 25 control subjects (normal volunt...
Bullous pemphigoid is associated with antibodies to a 230 kDa and a 180 kDa protein. In a literature...
The distributions in deposition of immunoreactants in bullous pemphigoid before and after initiating...
Background: There are several methods for the diagnosis of autoimmune bullous disease. Direct immuno...
BACKGROUND Direct immunofluorescence microscopy (DIF) studies constitute the gold standard for di...
The subepidermal immunobullous diseases bullous pemphigoid (BP), cicatricial pemphigoid (CP), pemphi...
There are a number of controversies relating to studies of bullous pemphigold (BP) antigens from dif...
Direct immunofluorescence plays an important role in the diagnosis of autoimmune bullous diseases. T...
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigo...
Background: Direct immunofluorescence (DIF) testing is an important procedure in the diagnosis of au...
The purpose of indirect immunofluorescence microscopy is to detect circulating antibodies in patient...
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigo...